News and Views
Recent Price Movement and Market Comparison
Hester Biosciences has experienced a sustained downward trajectory over multiple time frames. In the past week, the stock fell by 8.27%, significantly underperforming the Sensex’s modest decline of 2.43%. Over the last month, the stock’s loss widened to 13.59%, compared to the Sensex’s 4.66% drop. Year-to-date, the stock has declined by 13.31%, while the benchmark index has only fallen 4.32%. The longer-term picture is even more concerning, with a one-year return of -36.43% against the Sensex’s positive 6.56% gain. Over three and five years, the stock has lagged the market by substantial margins, posting negative returns of 23.04% and 16.71% respectively, while the Sensex surged 33.80% and 66.82% in the same periods.
...
Read full news article
